CCA
CORT icon

Catalyst Capital Advisors’s Corcept Therapeutics CORT Stock Holding History

Catalyst Capital Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7K Hold
100
– – ﹤0.01% 367
2026
Q1 		$4.03K Sell
100
-16,225
-99% -$607K ﹤0.01% 367
2025
Q4 		$568K Sell
16,325
-800
-5% -$62.8K 0.01% 172
2025
Q3 		$1.42M Sell
17,125
-975
-5% -$70.6K 0.03% 131
2025
Q2 		$1.33M Sell
18,100
-1,100
-6% -$79.8K 0.03% 136
2025
Q1 		$2.19M Buy
+19,200
New +$1.17M 0.04% 108
2020
Q3 		– Sell
-160
Closed -$3K – 290
2020
Q2 		$3K Hold
160
– – ﹤0.01% 268
2020
Q1 		$2K Sell
160
-640
-80% -$7.92K ﹤0.01% 223
2019
Q4 		$10K Hold
800
– – ﹤0.01% 289
2019
Q3 		$11K Hold
800
– – ﹤0.01% 336
2019
Q2 		$9K Sell
800
-14,900
-95% -$166K ﹤0.01% 324
2019
Q1 		$184K Sell
15,700
-68,200
-81% -$847K 0.01% 201
2018
Q4 		$1.12M Buy
+83,900
New +$1.11M 0.04% 143
2018
Q2 		– Sell
-5,400
Closed -$89K – 500
2018
Q1 		$89K Sell
5,400
-62,500
-92% -$1.16M ﹤0.01% 275
2017
Q4 		$1.23M Sell
67,900
-4,250
-6% -$77K 0.05% 155
2017
Q3 		$1.39M Buy
72,150
+9,150
+15% +$136K 0.06% 147
2017
Q2 		$743K Buy
+63,000
New +$685K 0.03% 200
2014
Q4 		– Sell
-540,000
Closed -$1.45M – 506
2014
Q3 		$1.45M Hold
540,000
– – 0.19% 117
2014
Q2 		$1.51M Buy
+540,000
New +$1.59M 0.25% 115

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Catalyst Capital Advisors's CORT Position: Q2 2026 in Review

Catalyst Capital Advisors held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 100 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #367.

Catalyst Capital Advisors first reported a position in CORT in Q2 2014 and has held it in 19 quarters since. The position peaked at $2.19M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Catalyst Capital Advisors held 100 shares of Corcept Therapeutics worth $8.7K as of Q2 2026.
  • Catalyst Capital Advisors left its Corcept Therapeutics share count unchanged in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #367 holding.
  • Catalyst Capital Advisors first reported a position in Corcept Therapeutics in Q2 2014 and has held it in 19 quarters since.
  • Catalyst Capital Advisors's Corcept Therapeutics position peaked at $2.19M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.